Boerlin, V.

som 230 patient level sst 2 /liter effect receptor somatostatin gh levels subtype study analog treatment acromegalic patients sst 5 glucose insulin endocrinol acromegaly adenoma secretion expression concentration adenoma cells metab octreotide glucose levels sc injection acromegalic gh concentrations gh secretion gh release injection sst 5 subtype tumor 100 g oct mrna expression levels hormone response suppression release patients 6 efficacy sst 5 mrna growth hormone administration growth plasma affinity culler md control sst subtypes adenomas insulin levels culture inhibition group 12 patients analysis 72- h incubation profile sst 5 subtypes dosage action increase som 230. treatment days suppressive patient 12 amount november downloaded pattern lunch lambert igf-i serum lanreotide february somatostatin receptor subtypes